MedLink Neurology Home

Your First Place To Look™ for authoritative, in-depth articles covering the full spectrum of neurology!

Resource Centers

Behavioral & Cognitive Disorders
Childhood Degenerative & Metabolic Disorders
Developmental Malformations
Epilepsy & Seizures
Headaches & Pain
Infectious Disorders
Miscellaneous Neurology Disorders
Miscellaneous Pediatric Neurology Disorders
Movement Disorders
Neuro-Oncology
Neuro-Ophthalmology & Neuro-Otology
Neuroimmunology
Neuromuscular Disorders
Peripheral Neuropathies
Sleep Disorders
Stroke & Vascular Disorders

Recently Published Articles

Spinal meningioma
Epilepsy with progressive mental retardation
Lacunar infarction
Ketogenic diet in the treatment of epilepsy
Sleep and cerebral degenerative disorders

Site Overview - Key Features


Articles
1,200 continually-updated authoritative clinical reviews covering the entire spectrum of neurology.
Images and Videos
Nearly 3,000 illustrations, including video clips of neurologic disorders.
CME Information
Earn AMA PRA Category 1™ CME credits for routinely using MedLink Neurology.
Editorial Board
Distinguished Editorial Board and hundreds of expert authors.
External Resources
The world’s largest annotated directory of useful resources for neurologists.
Forum
Interact with your colleagues. Your privacy is protected.
Patient Handouts
Information for patients you can print or email when needed.
News
See what’s being published in the neurology and neuroscience literature.
Learn More

CME Information







MedLink Corporation is accredited by the ACCME to provide continuing medical education for physicians. Learn more.

Selected News

FDA approves first drug for eosinophilic granulomatosis with polyangiitis (Churg-Strauss Syndrome)
The US FDA expanded the approved use of mepolizumab to treat adult patients with eosinophilic granulomatosis with polyangiitis. This new indication provides the first FDA-approved therapy specifically to treat the rare autoimmune disease.
Drug for spinal muscular atrophy prompts ethical dilemmas
First drug for people with spinal muscular atrophy gives hope for improving the lives of patients with the rare disease, but the extraordinary cost of the drug and complicated logistics of delivering it present barriers for many patients.

Neurology Meetings

Neurology Meetings
A list of U.S. and international meetings, conferences, and symposiums of interest to neurologists.

Learn More About MedLink Neurology